Literature DB >> 25203030

OpenBiome remains open to serve the medical community.

Mark Smith1, Zain Kassam1, Carolyn Edelstein2, James Burgess2, Eric Alm1.   

Abstract

Mesh：

Year:  2014        PMID： 25203030     DOI： 10.1038/nbt.3006

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Policy: How to regulate faecal transplants.

Authors:  Mark B Smith; Colleen Kelly; Eric J Alm
Journal:  Nature       Date:  2014-02-20       Impact factor: 49.962

2.  Fecal transplantation poses dilemma for FDA.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2014-05       Impact factor: 54.908

3.  Acquired immunodeficiency syndrome and directed blood donations. A dilemma for American medicine.

Authors:  M S Kruskall; J Umlas
Journal:  Arch Surg       Date:  1988-01
  3 in total
  11 in total

1.  Microbial cocktails join fecal transplants in IBD treatment trials.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2015-08       Impact factor: 54.908

2.  Small Intestinal Bacterial Overgrowth: Should Screening Be Included in the Pre-fecal Microbiota Transplantation Evaluation?

Authors:  Jessica R Allegretti; Zain Kassam; Walter W Chan
Journal:  Dig Dis Sci       Date:  2017-11-29       Impact factor: 3.199

3.  Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.

Authors:  Monika Fischer; Brian Sipe; Yao-Wen Cheng; Emmalee Phelps; Nicholas Rogers; Sashidhar Sagi; Matthew Bohm; Huiping Xu; Zain Kassam
Journal:  Gut Microbes       Date:  2016-12-21

4.  Fecal Microbiota Transplantation: From Clostridium difficile to Inflammatory Bowel Disease.

Authors:  Robert J Gianotti; Alan C Moss
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-04

5.  Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug.

Authors:  Josbert J Keller; Maria Jgt Vehreschild; Christian L Hvas; Simon Md Jørgensen; Jouzas Kupciskas; Alexander Link; Chris Jj Mulder; Simon D Goldenberg; Ramesh Arasaradnam; Harry Sokol; Antonio Gasbarrini; Christoph Hoegenauer; Elizabeth M Terveer; Ed J Kuijper; Perttu Arkkila
Journal:  United European Gastroenterol J       Date:  2019-11-14       Impact factor: 4.623

6.  Stool processing speed and storage duration do not impact the clinical effectiveness of fecal microbiota transplantation.

Authors:  Jessica R Allegretti; Ryan J Elliott; Alim Ladha; Mary Njenga; Kurt Warren; Kelsey O'Brien; Shrish Budree; Majdi Osman; Monika Fischer; Colleen R Kelly; Zain Kassam
Journal:  Gut Microbes       Date:  2020-06-18

Review 7.  Functional Genomics and Its Bench-to-Bedside Translation Pertaining to the Identified Susceptibility Alleles and Loci in Ankylosing Spondylitis.

Authors:  Tony J Kenna; Aimee Hanson; Mary-Ellen Costello; Matthew A Brown
Journal:  Curr Rheumatol Rep       Date:  2016-10       Impact factor: 4.592

8.  Asymptomatic Clostridium difficile carriage rate post-fecal microbiota transplant is low: a prospective clinical and stool assessment.

Authors:  J R Allegretti; A S Allegretti; E Phelps; H Xu; Z Kassam; M Fischer
Journal:  Clin Microbiol Infect       Date:  2017-11-11       Impact factor: 8.067

Review 9.  The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.

Authors:  Tessa M Andermann; Jonathan U Peled; Christine Ho; Pavan Reddy; Marcie Riches; Rainer Storb; Takanori Teshima; Marcel R M van den Brink; Amin Alousi; Sophia Balderman; Patrizia Chiusolo; William B Clark; Ernst Holler; Alan Howard; Leslie S Kean; Andrew Y Koh; Philip L McCarthy; John M McCarty; Mohamad Mohty; Ryotaro Nakamura; Katy Rezvani; Brahm H Segal; Bronwen E Shaw; Elizabeth J Shpall; Anthony D Sung; Daniela Weber; Jennifer Whangbo; John R Wingard; William A Wood; Miguel-Angel Perales; Robert R Jenq; Ami S Bhatt
Journal:  Biol Blood Marrow Transplant       Date:  2018-02-19       Impact factor: 5.742

10.  Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium difficile Infection.

Authors:  Kyeong Ok Kim; Margot A Schwartz; Otto S T Lin; Michael V Chiorean; Michael Gluck
Journal:  Adv Ther       Date:  2019-06-01       Impact factor: 3.845
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.